Skip to main content

House bill · H.R. 8005 (119th Congress)

Stop Pills That Kill Act

U.S. House of Representatives

Latest action Sep 16, 2026

Sponsor: Gabe Evans (U.S. Representative, CO-8, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 23, 2026. About our data

Summary

Stop Pills That Kill Act This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances. Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine). The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Passed one of the two chambers; it still needs the other.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

As identified by Congress.gov.

Full history

  1. Sep 16, 2026

    Sent to the executive

    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    U.S. Senate

  2. Sep 15, 2026

    Considered Under Suspension of the rules. (consideration: cr H5674-5676)

    Considered under suspension of the rules. (consideration: CR H5674-5676)

  3. Sep 15, 2026

    Considered Under Suspension of the rules. (consideration: cr H5674-5676)

    Considered under suspension of the rules. (consideration: CR H5674-5676)

  4. Sep 15, 2026

    Debate - the House Proceeded With Forty Minutes of Debate on H.R. 8005.

    DEBATE - The House proceeded with forty minutes of debate on H.R. 8005.

    U.S. House of Representatives

  5. Sep 15, 2026

    Passed a chamber

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    U.S. House of Representatives

Show full history (23 earlier events)
  1. Sep 15, 2026

    Passed a chamber

    The title of the measure was amended. Agreed to without objection.

  2. Sep 15, 2026

    Passed a chamber

    The title of the measure was amended. Agreed to without objection.

  3. Jul 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  4. Jul 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  5. Jul 21, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  6. Jul 21, 2026

    Reported out of committee

    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 43 - 6.

  7. Jul 21, 2026

    Reported out of committee

    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 43 - 6.

  8. Jul 21, 2026

    Reported out of committee

    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 43 - 6.

  9. Jul 20, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  10. Jul 20, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  11. Jul 20, 2026

    Committee vote

    Committee Consideration and Mark-up Session Held

  12. Jul 15, 2026

    In committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

  13. Jul 15, 2026

    In committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

  14. Jul 15, 2026

    In committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

  15. Jul 15, 2026

    In committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

    U.S. House

  16. Jul 15, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  17. Jul 15, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  18. Jul 15, 2026

    Committee vote

    Subcommittee Consideration and Mark-up Session Held

  19. Mar 19, 2026

    Introduced

    Introduced in House

    U.S. House of Representatives

  20. Mar 19, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  21. Mar 19, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

  22. Mar 19, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

  23. Mar 19, 2026

    Referred to committee

    Referred to the Subcommittee on Health.

Read the record